The objective of the proposed study is to determine the contribution of polymorphic variation in ten candidate genes involved in lipid metabolism (A-IV, B, D, E, H, APO(a), LDL receptor, hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein) in determining quantitative lipoprotein-lipid levels and cardiovascular risk factors in Anglo and Hispanic populations of the San Luis Valley in southern Colorado. Genetic variation in the gene products of A-IV, E, H, and APO(a) will be determined by IEF and SDS/immunoblotting; gene variation at the APOB, D, LDL receptor, hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein will be assayed by polymerase chain reaction protocols and using cloned cDNA probes for RFLPs analyses. Direct haplotype analysis of individuals will employ a strategy using RFLP analysis combined with the use of allele specific oligonucleotides. Quantitative levels of apolipoprotein B, E, H and APO (a) will be determined by immunological techniques. These data and prior data on levels of triglycerides, total cholesterol, HDL-, LDL- and HDL subfraction cholesterol will be used in the quantitative genetic analysis. Estimates of the effect of alleles at each of the genetic loci on the quantitative apolipoprotein and lipoprotein levels will employ the measured genotype approach. The effort of multisite haplotypes for RFLPs at various loci will be estimated using the same methods. For common alleles in each system the interaction of alleles at independent genetic loci in determining quantitative variables will be estimated. Dietary information from the San Luis Valley population will be used to estimate cholesterol intake identified. Allelic effects will be estimated in these groups to gain insight into the effect of dietary cholesterol intake of the estimated allelic effects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL044672-01A1
Application #
3363479
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1991-05-01
Project End
1994-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Public Health
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wang, G Q; DiPietro, M; Roeder, K et al. (2003) Cladistic analysis of human apolipoprotein a4 polymorphisms in relation to quantitative plasma lipid risk factors of coronary heart disease. Ann Hum Genet 67:107-24
Pfaff, C L; Parra, E J; Bonilla, C et al. (2001) Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet 68:198-207
Evans, R W; Shpilberg, O; Shaten, B J et al. (2001) Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial. J Clin Epidemiol 54:51-7
Razzaghi, H; Day, B W; McClure, R J et al. (2001) Structure-function analysis of D9N and N291S mutations in human lipoprotein lipase using molecular modelling. J Mol Graph Model 19:487-94, 587-90
Razzaghi, H; Aston, C E; Hamman, R F et al. (2000) Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107:257-67
Chiu, L; Hamman, R F; Kamboh, M I (2000) Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic Whites and Hispanics. Hum Biol 72:821-35
Saha, N; Aston, C E; Low, P S et al. (2000) Racial and genetic determinants of plasma factor XIII activity. Genet Epidemiol 19:440-55
Kamboh, M I; Aston, C E; Hamman, R F (2000) DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile. Atherosclerosis 152:193-201
Mehdi, H; Aston, C E; Sanghera, D K et al. (1999) Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet 105:63-71
Saha, N; Sanghera, D K; Kamboh, M I (1999) The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 29:999-1002

Showing the most recent 10 out of 39 publications